Feeding strategies to reduce liver abscesses
Liver abscess rates in smaller pen research studies are often much higher than we see in commercial operations. While it’s not entirely clear why this occurs, it does provide an opportunity to accurately assess the effectiveness of different mitigation strategies at a lower cost than a very large commercial scale trial.
Completed: 2023
Diving deep into liver abscess development
The combination of genomic and metabolic data from both bacteria and animals will provide insights into how liver abscesses develop, help identify vaccine or drug development targets, and potentially contribute to better diagnostic techniques.
Started: 2022
Exploring non-antibiotic treatment options to manage Mycoplasma bovis
While this project is very early stage drug discovery research, and will certainly not eliminate M. bovis infections immediately, it is exploring a new approach that potentially can improve the management of this bacteria in the future.
Started: 2021
Showing 13-24 of 46